...
search icon
indv-img

Indivior PLC Ordinary Shares, Common Stock

INDV

NSQ

$8.735

-$0.28

(-3.11%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.18B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
450.5
Volume info-icon
This is the total number of shares traded during the most recent trading day.
239.03K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.32
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$7.33 L
$19.13 H
$8.735

About Indivior PLC Ordinary Shares, Common Stock

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameINDVSectorS&P500
1-Week Return0.78%0.44%0.38%
1-Month Return-9.81%-7.69%-7.19%
3-Month Return-22.66%-3.35%-11.93%
6-Month Return4.89%-11.09%-9.6%
1-Year Return-53.22%-2.13%5.2%
3-Year Return108.32%-1.18%20.2%
5-Year Return1466.96%34.44%83.57%
10-Year Return191.21%84.87%153.9%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue689.68M777.48M884.63M1.09B1.19B[{"date":"2020-12-31","value":58.05,"profit":true},{"date":"2021-12-31","value":65.44,"profit":true},{"date":"2022-12-31","value":74.46,"profit":true},{"date":"2023-12-31","value":92,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue116.19M137.61M168.87M186.00M231.00M[{"date":"2020-12-31","value":50.3,"profit":true},{"date":"2021-12-31","value":59.57,"profit":true},{"date":"2022-12-31","value":73.11,"profit":true},{"date":"2023-12-31","value":80.52,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit573.49M639.87M715.75M907.00M957.00M[{"date":"2020-12-31","value":59.93,"profit":true},{"date":"2021-12-31","value":66.86,"profit":true},{"date":"2022-12-31","value":74.79,"profit":true},{"date":"2023-12-31","value":94.78,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin83.15%82.30%80.91%82.98%80.56%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":98.98,"profit":true},{"date":"2022-12-31","value":97.3,"profit":true},{"date":"2023-12-31","value":99.8,"profit":true},{"date":"2024-12-31","value":96.88,"profit":true}]
Operating Expenses479.69M456.07M510.55M911.00M925.00M[{"date":"2020-12-31","value":51.86,"profit":true},{"date":"2021-12-31","value":49.3,"profit":true},{"date":"2022-12-31","value":55.19,"profit":true},{"date":"2023-12-31","value":98.49,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income93.81M183.80M205.20M(4.00M)32.00M[{"date":"2020-12-31","value":45.71,"profit":true},{"date":"2021-12-31","value":89.57,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1.95,"profit":false},{"date":"2024-12-31","value":15.59,"profit":true}]
Total Non-Operating Income/Expense(34.00M)(46.00M)(20.00M)10.00M(36.00M)[{"date":"2020-12-31","value":-340,"profit":false},{"date":"2021-12-31","value":-460,"profit":false},{"date":"2022-12-31","value":-200,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-360,"profit":false}]
Pre-Tax Income(184.41M)186.75M(93.27M)1.00M14.00M[{"date":"2020-12-31","value":-98.75,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-49.95,"profit":false},{"date":"2023-12-31","value":0.54,"profit":true},{"date":"2024-12-31","value":7.5,"profit":true}]
Income Taxes(26.65M)(14.74M)(41.24M)(1.00M)11.00M[{"date":"2020-12-31","value":-242.27,"profit":false},{"date":"2021-12-31","value":-134.03,"profit":false},{"date":"2022-12-31","value":-374.88,"profit":false},{"date":"2023-12-31","value":-9.09,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes(157.76M)201.50M(52.04M)2.00M3.00M[{"date":"2020-12-31","value":-78.3,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-25.83,"profit":false},{"date":"2023-12-31","value":0.99,"profit":true},{"date":"2024-12-31","value":1.49,"profit":true}]
Income From Continuous Operations(148.00M)205.00M(53.00M)2.00M3.00M[{"date":"2020-12-31","value":-72.2,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-25.85,"profit":false},{"date":"2023-12-31","value":0.98,"profit":true},{"date":"2024-12-31","value":1.46,"profit":true}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(157.76M)205.00M(52.04M)2.00M2.00M[{"date":"2020-12-31","value":-76.96,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-25.38,"profit":false},{"date":"2023-12-31","value":0.98,"profit":true},{"date":"2024-12-31","value":0.98,"profit":true}]
EPS (Diluted)(1.05)1.31(0.44)0.24(0.07)[{"date":"2020-12-31","value":-80.24,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-33.71,"profit":false},{"date":"2023-12-31","value":18.31,"profit":true},{"date":"2024-12-31","value":-5.42,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

INDV
Cash Ratio 0.34
Current Ratio 0.89
Quick Ratio 0.70

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

INDV
ROA (LTM) 10.69%
ROE (LTM) 12.20%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

INDV
Debt Ratio Lower is generally better. Negative is bad. 1.26
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.26

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

INDV
Trailing PE 450.50
Forward PE NM
P/S (TTM) 0.95
P/B 145.25
Price/FCF NM
EV/R 0.99
EV/Ebitda 14.05

FAQs

What is Indivior PLC Ordinary Shares share price today?

Indivior PLC Ordinary Shares (INDV) share price today is $8.735

Can Indians buy Indivior PLC Ordinary Shares shares?

Yes, Indians can buy shares of Indivior PLC Ordinary Shares (INDV) on Vested. To buy Indivior PLC Ordinary Shares from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in INDV stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Indivior PLC Ordinary Shares be purchased?

Yes, you can purchase fractional shares of Indivior PLC Ordinary Shares (INDV) via the Vested app. You can start investing in Indivior PLC Ordinary Shares (INDV) with a minimum investment of $1.

How to invest in Indivior PLC Ordinary Shares shares from India?

You can invest in shares of Indivior PLC Ordinary Shares (INDV) via Vested in three simple steps:

  • Click on Sign Up or Invest in INDV stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Indivior PLC Ordinary Shares shares
What is Indivior PLC Ordinary Shares 52-week high and low stock price?

The 52-week high price of Indivior PLC Ordinary Shares (INDV) is $19.13. The 52-week low price of Indivior PLC Ordinary Shares (INDV) is $7.33.

What is Indivior PLC Ordinary Shares price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Indivior PLC Ordinary Shares (INDV) is 450.5

What is Indivior PLC Ordinary Shares price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Indivior PLC Ordinary Shares (INDV) is 145.25

What is the Market Cap of Indivior PLC Ordinary Shares?

The market capitalization of Indivior PLC Ordinary Shares (INDV) is $1.18B

What is Indivior PLC Ordinary Shares’s stock symbol?

The stock symbol (or ticker) of Indivior PLC Ordinary Shares is INDV

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top